B. Rael Cahn
Titre
Citée par
Citée par
Année
Meditation states and traits: EEG, ERP, and neuroimaging studies.
BR Cahn, J Polich
Psychological bulletin 132 (2), 180, 2006
20822006
Meditation states and traits: EEG, ERP, and neuroimaging studies.
BR Cahn, J Polich
Psychological bulletin 132 (2), 180, 2006
20822006
Trauma Symptom Inventory: Psychometrics and association with childhood and adult victimization in clinical samples
J Briere, DM Elliott, K Harris, A Cotman
Journal of Interpersonal Violence 10 (4), 387-401, 1995
3691995
Occipital gamma activation during Vipassana meditation
BR Cahn, A Delorme, J Polich
Cognitive processing 11 (1), 39-56, 2010
2412010
Meditation (Vipassana) and the P3a event-related brain potential
BR Cahn, J Polich
International journal of psychophysiology 72 (1), 51-60, 2009
2142009
Effects of psilocybin on time perception and temporal control of behaviour in humans
M Wittmann, O Carter, F Hasler, BR Cahn, U Grimberg, P Spring, D Hell, ...
Journal of Psychopharmacology 21 (1), 50-64, 2007
1812007
Event-related delta, theta, alpha and gamma correlates to auditory oddball processing during Vipassana meditation
BR Cahn, A Delorme, J Polich
Social cognitive and affective neuroscience 8 (1), 100-111, 2013
1012013
Awakening is not a metaphor: the effects of Buddhist meditation practices on basic wakefulness
WB Britton, JR Lindahl, BR Cahn, JH Davis, RE Goldman
Annals of the New York Academy of Sciences 1307, 64, 2014
832014
Cannabis and endocannabinoid modulators: Therapeutic promises and challenges
I Grant, BR Cahn
Clinical neuroscience research 5 (2-4), 185-199, 2005
802005
Yoga, meditation and mind-body health: increased BDNF, cortisol awakening response, and altered inflammatory marker expression after a 3-month yoga and meditation retreat
BR Cahn, MS Goodman, CT Peterson, R Maturi, PJ Mills
Frontiers in human neuroscience 11, 315, 2017
782017
Increased gamma brainwave amplitude compared to control in three different meditation traditions
C Braboszcz, BR Cahn, J Levy, M Fernandez, A Delorme
PLoS One 12 (1), e0170647, 2017
602017
The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations
M Kometer, BR Cahn, D Andel, OL Carter, FX Vollenweider
Biological psychiatry 69 (5), 399-406, 2011
552011
Critical analysis of the efficacy of meditation therapies for acute and subacute phase treatment of depressive disorders: a systematic review
FA Jain, RN Walsh, SJ Eisendrath, S Christensen, BR Cahn
Psychosomatics 56 (2), 140-152, 2015
502015
Future directions in meditation research: Recommendations for expanding the field of contemplative science
C Vieten, H Wahbeh, BR Cahn, K MacLean, M Estrada, P Mills, M Murphy, ...
PloS one 13 (11), e0205740, 2018
312018
Bid regulation of neuronal apoptosis
JR Leonard, C D’Sa, BR Cahn, SJ Korsmeyer, KA Roth
Developmental Brain Research 128 (2), 187-190, 2001
262001
Plasticity of visual attention in Isha yoga meditation practitioners before and after a 3-month retreat
C Braboszcz, BR Cahn, B Balakrishnan, RK Maturi, R Grandchamp, ...
Frontiers in psychology 4, 914, 2013
242013
Neurophysiologic correlates to sensory and cognitive processing in altered states of consciousness
BR Cahn
UC San Diego, 2007
82007
Meditation and the brain in health and disease
KCR Fox, BR Cahn
MindRxiv, 2018
72018
Effect of mindfulness-based relapse prevention on impulsivity trajectories among young adults in residential substance use disorder treatment
JP Davis, N Barr, ER Dworkin, TM Dumas, B Berey, G DiGuiseppi, ...
Mindfulness 10 (10), 1997-2009, 2019
62019
JPsychopharm
M Wittmann, O Carter, F Hasler, BR Cahn, U Grimberg, P Spring, D Hell, ...
Journal of Psychopharmacology 21 (1), 50-64, 2007
42007
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20